TG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI® (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features. read more
TG Therapeutics' team score is currently ranked in the Top 15% of similar sized companies on Comparably and placed 1st among its competitors. 90% of TG Therapeutics employees look forward to interacting with coworkers while 85% believe their company meetings are effective.
Rate Team the Highest
Ethnicity - Caucasian
+1%
Gender - Female
-17%
Ethnicity - Hispanic or Latino
-32%
Rate Team the Lowest
Experience - 1 to 3 Years
-34%
How TG Therapeutics' Team Score is Calculated
88
out of 100
How would you rate the quality of your coworkers?
Answer
Percent
Yes
85%
No
15%
Are your company's meetings effective?
Answer
Percent
Yes
90%
No
10%
Do you look forward to interacting with your coworkers?
Answer
Percent
Yes
33%
No
67%
Does Your Boss Hurt Your Company Culture?
TG Therapeutics Employee Reviews In Other Categories